Øresund Pharma ApS: Financial statements 2024
CVR: 39492059
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Øresund Pharma ApS (CVR 39492059) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 39,622,065 and a net result of DKK 13,707,320 compared with DKK 16,750,969 the year before. That is an increase of 3.6% compared with the year before. Equity in the 2024 report amounted to DKK 38,150,718. The solvency ratio was 47%. The company had 11 employees in the financial year.
- Gross Profit
- DKK 39,622,065
- Profit/Loss
- DKK 13,707,320
- Equity
- DKK 38,150,718
- Total Assets
- DKK 81,088,602
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 39.6 mio. | 13.7 mio. | 38.2 mio. | 11 |
| 2023 | - | 38.3 mio. | 16.8 mio. | 24.4 mio. | 9 |
| 2022 | - | 17.2 mio. | 4.3 mio. | 7.7 mio. | 6 |
| 2021 | - | 7.3 mio. | 281 t. | 3.4 mio. | 5 |
| 2020 | - | 2.8 mio. | -86 t. | 3.1 mio. | 4 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Øresund Pharma ApS has won the tender "Amgros 2025 1.400.a" issued by Amgros I/S worth 1,010,000 DKK.
Øresund Pharma ApS has won the tender "Amgros 2025 1.1302.a" issued by Amgros I/S worth 17,702,414 DKK.
Øresund Pharma ApS has won the tender "Amgros 2025 1.700.a" issued by Amgros I/S worth 313,301,544 DKK.
Øresund Pharma ApS has won the tender "Amgros 2025 1.1200.a" issued by Amgros I/S worth 101,036,383 DKK.
Øresund Pharma ApS has won the tender "Amgros 2025 1.1202.a" issued by Amgros I/S worth 90,124,932 DKK.
Øresund Pharma ApS has won the tender "Amgros 2025 2.3.b" issued by Amgros I/S worth 359,770,187 DKK.
Øresund Pharma ApS has won the tender "Amgros 2025 1.703.b" issued by Amgros I/S worth 12,600,000 DKK.
Øresund Pharma ApS has won the tender "Amgros 2025 1.1142.b" issued by Amgros I/S worth 153,000,000 DKK.
As of April 1, 2024, Svend Aage Johansen is registered as director of Øresund Pharma ApS.
Øresund Pharma ApS has published its annual report for 2023. Gross profit came to DKK 38,259,550, and the net result was DKK 16,750,969.
About Øresund Pharma ApS
Øresund Pharma ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Øresund Pharma IVS. The management consists of Patrick Halborg Cohn and Svend Aage Johansen. The company is owned by Machpali ApS and ESH Holding 2019 ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 39,702,011 and a net result of DKK 6,466,876 compared with DKK 13,707,320 the year before. Equity in the 2025 report amounted to DKK 44,617,595.